Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
October 6, 2025
Hematology Weekly News – October 6th 2025
October 6, 2025
Oncology Weekly News – October 6th 2025
October 4, 2025
UEG Week Preview: Key Gastroenterology Highlights to Watch
October 3, 2025
Public Health Weekly News – October 3rd 2025
October 3, 2025
Respiratory Video Recap—October 3, 2025
October 3, 2025
Latest Vaccine Research News – Sept 19th – Oct 2nd 2025
October 3, 2025
BioPharma Corporate Venture Capital (CVC) Investment Trends
October 3, 2025
Respiratory Today—October 3, 2025
October 3, 2025
Vaccines Weekly News – October 3rd 2025
October 2, 2025
Latest Cell and Gene Therapy News – Sept 17th to Oct 1st
October 2, 2025
Rare Diseases Weekly News – October 2nd 2025
October 2, 2025